Today’s top gainers include the company Celgene Corporation (NASDAQ:CELG) which is in the industry Biotechnology, gaining -0.02% today. In the last week its performance is 4.50%, and 14.32% for the past quarter. Currently, Celgene Corporation, CELG has a target price of 136.45, so today’s gain of -0.02% is a significant step towards its target price. The GAP today is therefore 0.43%.
Celgene Corporation (NASDAQ:CELG), has a market cap of 90179.01, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.10%.
At the current price of 116.25, it has a dividend yield of *TBA, and its target price is 136.45. This is with a profit margin of 19.90%, and total debt/equity of 0. Celgene Corporation (NASDAQ:CELG) has a P/E of 56.25, as well as a forward P/E of 16.54.
With a current EPS of 2.07, and a forecasted EPS growth for next year at 22.43%,Celgene Corporation (NASDAQ:CELG) has had a EPS growth for the past five years at 15.70%. For the next five years EPS growth is projected to be 21.83%.
Performance for the year is -12.39%. Since its IPO date on 3/26/1990, the total performance to date is -2.91%.
Volume today for Celgene Corporation (NASDAQ:CELG), is 2235238, while its average volume is 4488.65. Whilst the total gain today was -0.02%, it did have a day high of -1.16%.
Volatility for this week has been at 2.41%, and 2.16% for the month. The 52-week low for Celgene Corporation, CELG has been 25.03%, while the 52-week-high has reached -12.98%.
Looking at its return of investments, which is 8.90%, and its return on assets is 7.20%. Celgene Corporation (NASDAQ:CELG) has an operating margin of 28.40%. With a sales growth of 20.90% quarter over quarter. Bearing in mind that Celgene Corporation, CELG is in the sector Healthcare, its long-term debt/equity is 2.58, and has a current ratio of 4.6 and 4.4 for quick ratio.
So what is the value of Celgene Corporation? Well its PEG is 2.58, and the P/S is 9.31, along with a P/B of 16.26. Meanwhile it has a p/cash of 14.08.